SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-22-022349
Filing Date
2022-11-17
Accepted
2022-11-17 09:36:17
Documents
10
Period of Report
2022-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6834
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5163
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 235805
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 736
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 2936
6 GRAPHIC exhibit99-2xu001.jpg GRAPHIC 30506
7 GRAPHIC exhibit99-3xu003.jpg GRAPHIC 181655
8 GRAPHIC exhibit99-3xu004.jpg GRAPHIC 160713
9 GRAPHIC exhibit99-4xu003.jpg GRAPHIC 3017
10 GRAPHIC exhibit99-4xu004.jpg GRAPHIC 26168
  Complete submission text file 0001062993-22-022349.txt   806871
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 221396984
SIC: 2834 Pharmaceutical Preparations